Help Lines 954-785-1121
 


You are not logged in. Upgrade Here
 <<<Previous Mid Day Report     Next Mid Day Report >>> 
 <<<Previous After Market Report Next After Market Report >>> 
You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Sunday, February 25, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

 MIDDAY BREAKOUTS REPORT - WEDNESDAY, MAY 19TH, 2010
Previous Mid Day Report Next Mid Day Report >>>

DOW 10381.87 -129.08 (-1.23%) | NASDAQ 2284.9 -32.36 (-1.40%) | S&P 500 1111.3 -9.5 (-0.85%)
Report Released : 5/19/2010 12:58:51 PM
Price is: Above 52W High and Less Than 52W High but within 5% of the 52 Week High
Volume Is: At least 57.5% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page


NONE OF OUR FEATURED STOCKS MET TODAY'S SCREENING CRITERIA FOR VOLUME AND PRICE ACTION.


Symbol - Exchange - Industry Group
Company Name
Last Chg Day
High
52 WK Hi % From Hi Volume
% DAV
DAV
ABC - NYSE - Medical-Whlsle Drg/Suppl
Amerisourcebergen Corp
$31.19 -0.11
-0.34%
$31.49 $31.96 -2.42% 2,030,756
58.35%
3,480,300
Most Recent Note for ABC - 5/19/2010 12:18:57 PM
Perched near its all-time high after finding recent support at its 50 DMA line. It has traded up in 13 out of 15 months. Noted in mid-day report on 5/07/10 - "Earnings showed better increases in the 2 latest quarters but prior comparisons have been below guidelines and sales revenues growth has been below guidelines. It shown steady annual earnings (A criteria) growth in recent years."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CBPO - NASDAQ - DRUGS - Biotechnology
China Biologic Products
$14.01 +0.56
4.16%
$14.38 $14.38 -2.57% 159,878
124.71%
128,200
Most Recent Note for CBPO - 5/19/2010 12:35:02 PM
Small gap up and gain today helped it hit a new high. Recently rallying above the high from when it was last noted in the mid-day report on 1/11/10. The China-based Medical - Biomed/Biotech firm has earned high ranks. For the quarter ended March 31, 2010 its sales and earnings increases were just above the +25% guideline after erratic prior comparisons which were mostly strong.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
ESRX - NASDAQ - HEALTH SERVICES - Specialized Health Services
Express Scripts Hldg Co
$103.95 -0.18
-0.17%
$104.93 $106.30 -2.21% 1,323,137
62.07%
2,131,600
Most Recent Note for ESRX - 5/19/2010 12:39:20 PM
Hovering near all-time highs after promptly repairing a recent 50 DMA violation. It has a great annual earnings history (A criteria) and no overhead supply to act as resistance. Quarterly earnings and sales revenues comparisons have not shown strong and steady +25% or greater increases verus the year ago periods, leaving fundamental concerns.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
LRN - NYSE - Consumer Svcs-Education
Stride Inc
$24.77 -0.05
-0.20%
$25.27 $25.48 -2.79% 129,878
89.63%
144,900
Most Recent Note for LRN - 5/19/2010 12:48:36 PM
Annual earnings (A criteria) history and quarterly sales revenues and earnings growth has been good. Consolidating near its 52-week high after recently finding support near prior chart highs following a brief violation of its 50 DMA line.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
NUTR - NASDAQ - DRUGS - Drug Related Products
Nutraceutical Intl Corp
$15.22 -0.25
-1.62%
$15.46 $16.00 -4.88% 39,553
132.73%
29,800
Most Recent Note for NUTR - 5/19/2010 12:52:39 PM
Building a base-on-base type pattern. Fundamentals are below guidelines today for this vitamin and dietary supplement maker which was long ago (back in 2004) on the Featured Stocks list.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  

THESE ARE NOT BUY RECOMMENDATIONS!  Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time.  Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

 We appreciate any feedback members may wish to send via the inquiry form here.

Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us